Gavin Macbeath
First SEC filing: July 15, 2021 · Latest: July 15, 2021
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 1, 2026 | TCRX | A | 1,000,000 | · | · | 1,049,767 Direct | +2009.36% | Acquired | (price as of 2026-10-02) |
| Jan. 20, 2026 | TCRX | A | 1,165,000 | · | · | 1,165,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 3, 2025 | TCRX | A | 800,000 | · | · | 800,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 12, 2024 | TCRX | A | 160,000 | · | · | 160,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 13, 2023 | TCRX | A | 1,121,300 | · | · | 1,121,300 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 2, 2023 | TCRX | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-02) |
| July 25, 2022 | TCRX | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 18, 2022 | TCRX | A | 140,000 | · | · | 140,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 21, 2021 | TCRX | P | 57 | $6.19 | $353 | 49,767 Direct | +0.11% | Acquired | -94.8% (price as of 2026-10-02) |
| Sept. 20, 2021 | TCRX | P | 4,943 | $6.22 | $30,745 | 49,710 Direct | +11.04% | Acquired | -94.8% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 20, 2026 | TCRX | Stock Option (Right to Buy) | Voting Common Stock | $1.12 | Jan. 20, 2036 | 1,165,000 | Acquired |
| Jan. 3, 2025 | TCRX | Stock Option (Right to Buy) | Voting Common Stock | $3.06 | Jan. 3, 2035 | 800,000 | Acquired |
| Jan. 12, 2024 | TCRX | Stock Option (Right to Buy) | Voting Common Stock | $6.00 | Jan. 12, 2034 | 160,000 | Acquired |
| June 13, 2023 | TCRX | Stock Option (Right to Buy) | Voting Common Stock | $2.49 | June 12, 2033 | 1,121,300 | Acquired |
| Feb. 2, 2023 | TCRX | Stock Option (Right to Buy) | Voting Common Stock | $1.81 | Feb. 1, 2033 | 40,000 | Acquired |
| July 25, 2022 | TCRX | Stock Option (Right to Buy) | Voting Common Stock | $3.27 | July 24, 2032 | 100,000 | Acquired |
| Jan. 18, 2022 | TCRX | Stock Option (Right to Buy) | Voting Common Stock | $4.85 | Jan. 17, 2032 | 140,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $665,000 | · | · | · | $139,650 | · | $14,000 | $2,801,450 |
| 2024 | $620,000 | · | · | · | $392,000 | · | $13,727 | $1,760,671 |
| 2023 | $545,121 | · | · | $2,342,541 | $296,000 | · | $12,392 | $3,196,054 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.